- Report
- May 2023
- 9 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- May 2021
- 121 Pages
Global
€4533EUR$4,750USD£3,798GBP
- Report
- August 2024
- 315 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- April 2022
- 193 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- January 2022
- 270 Pages
Global
From €3543EUR$3,712USD£2,968GBP
The Cardiac Ablation Device market is a subset of the Cardiovascular Devices market, which includes a variety of medical devices used to diagnose and treat cardiovascular diseases. Cardiac ablation devices are used to treat cardiac arrhythmias, or irregular heartbeats, by destroying or removing tissue in the heart that is causing the arrhythmia. These devices use energy sources such as radiofrequency, cryoablation, and laser ablation to target and ablate the tissue.
Cardiac ablation devices are used in a variety of settings, including hospitals, clinics, and ambulatory surgical centers. The market is expected to grow due to increasing prevalence of cardiovascular diseases, technological advancements, and increasing demand for minimally invasive procedures.
Some companies in the Cardiac Ablation Device market include Medtronic, Boston Scientific, Abbott, Biosense Webster, and St. Jude Medical. Show Less Read more